Mythili Koneru
Technik-/Wissenschafts-/F&E-Leiter bei LEGEND BIOTECH CORPORATION
Profil
Mythili Koneru is currently the Chief Medical Officer at Legend Biotech Corp.
Prior to this, she was the Chief Medical Officer at Marker Therapeutics, Inc. from 2019 to 2023.
She also worked as an Associate Vice President-Immuno-Oncology at Eli Lilly & Co. from 2015 to 2019.
Koneru received her undergraduate degree from The University of Chicago and her doctorate from New York University and Robert Wood Johnson Medical School.
Aktive Positionen von Mythili Koneru
| Unternehmen | Position | Beginn |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 11.04.2023 |
Ehemalige bekannte Positionen von Mythili Koneru
| Unternehmen | Position | Ende |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.02.2019 |
Ausbildung von Mythili Koneru
| The University of Chicago | Undergraduate Degree |
| New York University | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
